methylprednisolone has been researched along with Cerebral Infarction, Middle Cerebral Artery in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, YF; Li, QF; Zhang, Q; Zhang, ZX | 1 |
| Cheng, RH; Guo, YF; Liao, WQ; Pan, WH; Yao, ZR; Yu, H | 1 |
| Hou, YP; Jing, YH; Song, YF; Yin, J | 1 |
| Bloos, G; Harscher, S; Möller, U; Pfleiderer, SO; Terborg, C; Witte, OW | 1 |
| Borlongan, CV; Hess, DC; Yu, G | 1 |
| Murphy, EJ; Slivka, AP | 1 |
6 other study(ies) available for methylprednisolone and Cerebral Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Acute progressive stroke with middle cerebral artery occlusion caused by idiopathic hypereosinophilic syndrome: a case report.
Topics: Angiography, Digital Subtraction; Brain Ischemia; Female; Humans; Hypereosinophilic Syndrome; Infarction, Middle Cerebral Artery; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Stroke; Tomography, X-Ray Computed | 2020 |
Successful treatment of neurological malignant atrophic papulosis in child by corticosteroid combined with intravenous immunoglobulin.
Topics: Anti-Inflammatory Agents; Blepharoptosis; Brain; Cerebral Angiography; Child; Combined Modality Therapy; Diagnosis, Differential; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Infarction, Middle Cerebral Artery; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Malignant Atrophic Papulosis; Methylprednisolone; Skin | 2014 |
Methylprednisolone improves the survival of new neurons following transient cerebral ischemia in rats.
Topics: Analysis of Variance; Animals; Brain; Bromodeoxyuridine; Cell Count; Cell Differentiation; Cell Proliferation; Cerebral Infarction; Disease Models, Animal; Doublecortin Protein; Enzyme-Linked Immunosorbent Assay; Functional Laterality; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; Interleukin-6; Male; Methylprednisolone; Nerve Tissue Proteins; Neurogenesis; Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Reperfusion; RNA, Messenger; Statistics, Nonparametric; Time Factors; Tumor Necrosis Factor-alpha | 2012 |
[Cerebral vasospasms with hemodynamic infarctions as a complication of HELLP syndrome].
Topics: Adult; Cesarean Section; Diagnostic Imaging; Dose-Response Relationship, Drug; Female; Follow-Up Studies; HELLP Syndrome; Humans; Infarction, Middle Cerebral Artery; Magnesium Sulfate; Methylprednisolone; Neurologic Examination; Neuropsychological Tests; Nimodipine; Postoperative Complications; Pregnancy; Pregnancy Trimester, Third; Puerperal Disorders; Vasospasm, Intracranial | 2003 |
Combined cyclosporine-A and methylprednisolone treatment exerts partial and transient neuroprotection against ischemic stroke.
Topics: Animals; Brain Ischemia; Cerebral Infarction; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Functional Laterality; Infarction, Middle Cerebral Artery; Male; Methylprednisolone; Movement Disorders; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Stroke; Treatment Outcome | 2004 |
High-dose methylprednisolone treatment in experimental focal cerebral ischemia.
Topics: Animals; Brain Edema; Brain Ischemia; Carotid Arteries; Cerebral Cortex; Cerebral Infarction; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Infarction, Middle Cerebral Artery; Male; Methylprednisolone; Rats; Rats, Inbred SHR; Treatment Outcome; Water | 2001 |